A transgenic system for targeted ablation of reproductive and maternal-effect genes

© 2021. Published by The Company of Biologists Ltd..

Maternally provided gene products regulate the earliest events of embryonic life, including formation of the oocyte that will develop into an egg, and eventually into an embryo. Forward genetic screens have provided invaluable insights into the molecular regulation of embryonic development, including the essential contributions of some genes whose products must be provided to the transcriptionally silent early embryo for normal embryogenesis, called maternal-effect genes. However, other maternal-effect genes are not accessible due to their essential zygotic functions during embryonic development. Identifying these regulators is essential to fill the large gaps in our understanding of the mechanisms and molecular pathways contributing to fertility and to maternally regulated developmental processes. To identify these maternal factors, it is necessary to bypass the earlier requirement for these genes so that their potential later functions can be investigated. Here, we report reverse genetic systems to identify genes with essential roles in zebrafish reproductive and maternal-effect processes. As proof of principle and to assess the efficiency and robustness of mutagenesis, we used these transgenic systems to disrupt two genes with known maternal-effect functions: kif5ba and bucky ball.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:148

Enthalten in:

Development (Cambridge, England) - 148(2021), 12 vom: 15. Juni

Sprache:

Englisch

Beteiligte Personen:

Bertho, Sylvain [VerfasserIn]
Kaufman, Odelya [VerfasserIn]
Lee, KathyAnn [VerfasserIn]
Santos-Ledo, Adrian [VerfasserIn]
Dellal, Daniel [VerfasserIn]
Marlow, Florence L [VerfasserIn]

Links:

Volltext

Themen:

Germ cells
Journal Article
Maternal effect
Mutagenesis
Research Support, N.I.H., Extramural

Anmerkungen:

Date Completed 02.08.2021

Date Revised 16.07.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1242/dev.198010

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM326907289